China Oncology ›› 2022, Vol. 32 ›› Issue (2): 106-117.doi: 10.19401/j.cnki.1007-3639.2022.02.002
Previous Articles Next Articles
ZHAO Jiaxian1,2, JIANG Daohuai3,4,5, CONG Binbin1,2, GAO Fei3,4(), WANG Yongsheng1,2()
Received:
2021-12-24
Revised:
2022-01-10
Online:
2022-02-28
Published:
2022-03-08
Contact:
GAO Fei, WANG Yongsheng
E-mail:gaofei@shanghaitech.edu.cn;wangysh2008@aliyun.com
CLC Number:
ZHAO Jiaxian, JIANG Daohuai, CONG Binbin, GAO Fei, WANG Yongsheng. Basic research on photoacoustic sensing and imaging system for detecting sentinel lymph node in breast cancer[J]. China Oncology, 2022, 32(2): 106-117.
Fig. 1
Comparison of optical absorption spectra of different photoacoustic agents A: The absorption peaks of ICG and ICG-RIT were 780-800 nm; B: The light absorption peaks of methylene blue, methemoglobin, oxyhemoglobin and deoxyhemoglobin were located at 660-680 nm, 620-640 nm and below 600 nm, respectively."
Tab. 1
Amplitudes of ICG-RIT phantoms with different concentrations at different depths"
Depth D/mm | PA intensity of different agents U/mV | MB | Chicken breast tissue | ||||
---|---|---|---|---|---|---|---|
100%ICG-RIT | 50%ICG-RIT | 25%ICG-RIT | 12.5%ICG-RIT | 6.25%ICG-RIT | |||
0.00 | 26.70 | 20.99 | 12.60 | 9.79 | 9.51 | 19.45 | 0 |
15.13 | 15.80 | 12.04 | 9.66 | 9.23 | 6.99 | 11.06 | |
24.84 | 13.58 | 8.39 | 7.84 | 7.41 | 6.17 | 9.93 | |
39.72 | 10.22 | 7.56 | 6.85 | 4.61 | 3.78 | 5.73 | |
52.42 | 5.87 | 4.62 | 3.42 | 3.36 | 0.00 | 4.34 |
Fig. 5
Photoacoustic signals of 25% concentration ICG-RIT phantoms at different depths A: PA signal amplitude was 11.20 mV; Depth was 6.15 mm; B: PA signal amplitude was 8.99 mV; Depth was 17.37 mm; C: PA signal amplitude was 7.00 mV; Depth was 28.56 mm; D: PA signal amplitude was 6.25 mV; Depth was 43.50 mm; E: PA signal amplitude was 2.75 mV; Depth was 62.22 mm."
Fig. 6
Photoacoustic signals of 6.25% concentration ICG-RIT phantoms at different depths A: PA signal amplitude was 13.24 mV; Depth was 6.81 mm; B: PA signal amplitude was 12.25 mV; Depth was 14.73 mm; C: PA signal amplitude was 5.00 mV; Depth was 19.14 mm; D: PA signal amplitude was 2.74 mV; Depth was 33.00 mm; E: Photoacoustic signal at 46.95 mm depth was not used because of the low differentiation."
Fig. 8
Photoacoustic signals SLN at different depths A: The photoacoustic signal of axillary fat; B: PA signal amplitude was 99 mV; Depth was 9.18 mm; C: PA signal amplitude was 72 mV; Depth: 17.37 mm; D: PA signal amplitude was 59 mV; Depth was 25.60 mm; E: PA signal amplitude was 31 mV; Depth was 32.72 mm."
Fig. 9
Photoacoustic images and ultrasound images of SLN at different depths A, B: Both PAI and US imaged SLN under about 1 cm thick axillary fat; C, D: Both PAI and US imaged SLN under about 2.5 cm thick axillary fat; E: No significant SLN signal was found in PAI under about 4 cm thick axillary fat; F: US imaged SLN under about 4 cm thick axillary fat."
Fig. 10
Amplitudes and photoacoustic images after injection of ICG-RIT A, B: No significant signal of the popliteal LNs in the PASS and PAI was observed with no ICG-RIT injection; C, D: Characteristic photoacoustic signal in the PASS and PAI of the popliteal LNs was detected at 10.05 mm depth after ICG-RIT injection; E, F: No significant signal of the iliac LNs in the PASS and PAI was observed after ICG-RIT injection; G, H: No obvious staining of the popliteal LNs and the iliac LNs dissected along photoacoustic signal."
Fig. 11
Amplitudes and photoacoustic images after injection of MB A, B: Characteristic photoacoustic signal in the PASS and PAI of the popliteal LNs was detected at 6.93 mm depth after MB injection; C, D: Characteristic photoacoustic signal in the PASS and PAI of the iliac LNs was detected at 14.67 mm depth after MB injection; E, F: Obvious staining of the popliteal LNs and the iliac LNs dissected along photoacoustic signal."
Fig. 12
Amplitudes of ex vivo lymph nodes A: ICG-RIT injection ex vivo popliteal LNs PA signal amplitude was 2.50 mV; B: ICG-RIT injection ex vivo popliteal LNs PA signal amplitude was 0 mV; C: MB injection ex vivo popliteal LNs PA signal amplitude was 20.25 mV; D: MB injection ex vivo popliteal LNs PA signal amplitude was 7.74 mV."
[1] | PARK Y H,, SENKUS-KONEFKA E,, IM S A, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS[J]. Ann Oncol, 2020,31(4):451-469. |
[2] | GRADISHAR W J,, ANDERSON B O,, ABRAHAM J, et al. Breast cancer, version 3. 2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020,18(4):452-478. |
[3] | GIULIANO A E,, BALLMAN K V,, MCCALL L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial[J]. JAMA, 2017,318(10):918-926. |
[4] | LI J Y,, CHEN X,, QI M, et al. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: a systematic review and meta-analysis[J]. PLoS One, 2018,13(9):e0204364. |
[5] | RUBIO I T,, DIAZ-BOTERO S,, ESGUEVA A, et al. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer[J]. Eur J Surg Oncol, 2015,41(1):46-51. |
[6] | CONG B B,, SUN X,, SONG X R, et al. Preparation study of indocyanine green-rituximab: a new receptor-targeted tracer for sentinel lymph node in breast cancer[J]. Oncotarget, 2016,7(30):47526-47535. |
[7] | 丛斌斌,, 刘治国,, 孙晓, 等. 新型荧光靶向前哨淋巴结示踪剂的验证研究[J]. 中国癌症杂志, 2020,30(3):179-185. |
CONG B B,, LIU Z G,, SUN X, et al. The validation study of a new fluorescence-target tracer for sentinel lymph node biopsy[J]. China Oncol, 2020,30(3):179-185. | |
[8] | 赵家贤,, 王春建,, 丛斌斌, 等. 乳腺癌前哨淋巴结活检光声示踪剂的进展与展望[J]. 中国癌症杂志, 2021,31(10):873-878. |
ZHAO J X,, WANG C J,, CONG B B, et al. Research progress of photoacoustic imaging in sentinel lymph node biopsy in breast cancer[J]. China Oncol, 2021,31(10):873-878. | |
[9] | WEBER J,, BEARD P C,, BOHNDIEK S E. Contrast agents for molecular photoacoustic imaging[J]. Nat Methods, 2016,13(8):639-650. |
[10] | KIM C,, SONG K H,, GAO F, et al. Sentinel lymph nodes and lymphatic vessels: noninvasive dual-modality in vivo mapping by using indocyanine green in rats: volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging[J]. Radiology, 2010,255(2):442-450. |
[11] | LEE J,, EL-ABADDI N,, DUKE A, et al. Noninvasive in vivo monitoring of methemoglobin formation and reduction with broadband diffuse optical spectroscopy[J]. J Appl Physiol (1985), 2006,100(2):615-622. |
[12] | TROMBERG B J,, COQUOZ O,, FISHKIN J B, et al. Non-invasive measurements of breast tissue optical properties using frequency-domain photon migration[J]. Philos Trans R Soc Lond B Biol Sci, 1997,352(1354):661-668. |
[13] | MARQUEZ G,, WANG L V,, LIN S P, et al. Anisotropy in the absorption and scattering spectra of chicken breast tissue[J]. Appl Opt, 1998,37(4):798-804. |
[14] | 韩建红,, 甘仲霖,, 李达兵, 等. 三种鼠淋巴引流特点的比较研究[J]. 泸州医学院学报, 2015,38(4):388-392. |
HAN J H,, GAN Z L,, LI D B, et al. Comparative study of lymphatic drainage patterns on three species of murine[J]. J Luzhou Med Coll, 2015,38(4):388-392. | |
[15] | 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021,31(10):954-1040. |
The Society of Breast Cancer China Anti-Cancer Association. Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2021 edition)[J]. China Oncol, 2021,31(10):954-1040. | |
[16] | TIAN C L,, SUN X,, CONG B B, et al. Murine model study of a new receptor-targeted tracer for sentinel lymph node in breast cancer[J]. J Breast Cancer, 2019,22(2):274-284. |
[1] | XU Hua, LIU Ying, ZHANG Yi, WANG Tingliang, WANG Tao, HE Jinguang, LUO Jie, DONG Liping, WANG Hairong, DONG Jiasheng, XU Yuanbing. Application of CT angiography in delayed DIEP flap breast reconstruction [J]. China Oncology, 2022, 32(2): 125-133. |
[2] | WANG Jiahui, JIANG Linlan, SHEN Zan. New progress and prospect of breast cancer bone metastasis research from mechanism to clinic [J]. China Oncology, 2022, 32(2): 172-176. |
[3] | Chinese Anti-Cancer Association, Committee of Breast Cancer Society. Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2021 CACA-CBCS [J]. China Oncology, 2022, 32(2): 177-190. |
[4] | ZHANG Chi, CHEN Jiahui, LIN Jinyi, WANG Yan, ZHANG Sijia, ZHU Wei, CHENG Leilei. Validation of a scale for evaluating the cardiovascular risk after breast cancer therapy: the clinical scale for breast cancer treatment related cardiovascular toxicity [J]. China Oncology, 2022, 32(1): 54-60. |
[5] | JIN Yizi, LIN Mingxi, ZHANG Jian. Targeting DNA damage response deficiency in the treatment of breast cancer [J]. China Oncology, 2022, 32(1): 61-67. |
[6] | Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition) . Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) [J]. China Oncology, 2022, 32(1): 80-89. |
[7] | ZHANG Xiaoyan , LI Qingxiang , LIU Yong , LI Hang , QIU Lijuan , FENG Xinran , TAN Liming . A study on the correlation between HMGB1 and clinical characteristics and immune function in patients with breast cancer [J]. China Oncology, 2021, 31(9): 783-788. |
[8] | CAO Ailing, CAO Zhe, ZHOU Jian. Effects of docetaxel combined with thymosin α1 on number of Treg in immune microenvironment of rats with breast cancer and its mechanism [J]. China Oncology, 2021, 31(9): 799-806. |
[9] | YAO Jia , LI Guanqiao , YANG Shiping , SU Huiluan . Effect of hsa-miR-98-5p/DKK3 signal axis on biological behavior of breast cancer cells [J]. China Oncology, 2021, 31(9): 807-816. |
[10] | CONG Binbin, WANG Yongsheng. Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer [J]. China Oncology, 2021, 31(8): 689-696. |
[11] | ZHU Yihui, LI Ting, HU Xichun. Clinical research progress and prospect of trastuzumab deruxtecan [J]. China Oncology, 2021, 31(8): 754-761. |
[12] | DING Gaofeng, GUO Leiming, LU Yufei. The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients [J]. China Oncology, 2021, 31(7): 589-595. |
[13] | JIN Youping, LI Luying, ZHOU Ping. A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism [J]. China Oncology, 2021, 31(7): 596-604. |
[14] | XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei . Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells [J]. China Oncology, 2021, 31(7): 605-615. |
[15] | ZENG Feng , LI Dan , SHAO Xinxin , ZHANG Nengying , CHEN Xinghan , CHENG Xiaoming . Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study [J]. China Oncology, 2021, 31(4): 323-329. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
沪ICP备12009617
Powered by Beijing Magtech Co. Ltd